Adopted Trials - Oesophageal

Acronym: ST03
Full Title
A randomised phase II/III trial of peri-operative chemotherapy with or without bevacizumab in operable stomach and gastro-oesophageal junction adenocarcinomas
Treatment: Chemotherapy
Phase: 2/3
Current status: Open to recruitment
Chief Investigator: Prof David Cunningham
Type of trial: Early Phase
Website:

Acronym: NWCOG-3
Full Title
A phase I/II study of Docetaxel (Taxotere), Cisplatinum and Capecitabine (Xeloda) (TCX) in patients with advanced oesophago-gastric cancer
Treatment: Chemotherapy
Phase: 1/2
Current status: Open to recruitment
Chief Investigator: Dr Simon Gollins
Type of trial: Early Phase
Website:

Acronym: SCOPE 1
Full Title
A randomised phase II/III multi-centre clinical trial of definitive chemoradiation, with or without Cetuximab, in carcinoma of the oesophagus
Treatment: Other (please specify in Notes)
Phase: 2/3
Current status: Open to recruitment
Chief Investigator: Dr Tom Crosby
Type of trial: Early Phase

image 1 iamge 2 iamge 2
LCTU About Us | Site Map | Contact Us | ©2008 Liverpool ECMC |